Realheart is a public company listed on Nasdaq First North Growth Market since December 17 2021, under the name (HEART).
Realheart’s total artificial heart, Realheart® TAH, was recently implanted in a sheep with very good results.
Hear Realheart’s Chief Medical Officer and cardiac surgeon Ulf Kjellman about experiences, results and hopes for the future.
The Swedish innovation tradition has provided the world with medical technological inventions such as the heart and lung machine, the pacemaker and the dialysis machine. The next great innovation is Realheart’s artificial heart, Realheart TAH, a Swedish invention that not only saves lives but also creates a better quality of a prolonged life.